Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2018, Article ID 1015239, 12 pages
https://doi.org/10.1155/2018/1015239
Review Article

Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review

1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
2Saw Swee Hock School of Public Health, National University of Singapore, Singapore
3Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
4Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Correspondence should be addressed to Jinyu Liu; moc.361@uynalyrrehc

Received 30 August 2018; Accepted 18 October 2018; Published 18 November 2018

Academic Editor: Sébastien Bonnet

Copyright © 2018 Ruxu You et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ruxu You, Xinyu Qian, Weijing Tang, et al., “Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review,” Canadian Respiratory Journal, vol. 2018, Article ID 1015239, 12 pages, 2018. https://doi.org/10.1155/2018/1015239.